设为首页
加入收藏
首页
药品资讯
全球药品分类
药商发布新闻
关于我们
采购流程
我要投稿
当前位置:
首页
->
药品数椐
->
Ireland[爱尔兰药品]
Ireland[爱尔兰药品]
Xarelto 2.5 mg film-coated tablets
1.Nameofthemedicinalproduct Xarelto2.5mgfilm-coatedtablets 2.Qualitativeandquantitativecomposition Eachfilm-coatedtabletcontains2.5mgrivaroxaban. Excipientwithknownef..
录入者:
admin
发表于:
2015-02-06
查阅全文...
Xarelto 20mg film-coated tablets
1.Nameofthemedicinalproduct Xarelto20mgfilm-coatedtablets 2.Qualitativeandquantitativecomposition Eachfilm-coatedtabletcontains20mgrivaroxaban. Excipientwithknowneffect: Eachfilm..
录入者:
admin
发表于:
2015-02-06
查阅全文...
Creon for Children 5000 Gastro-resistant GranulesPancreatin
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:
admin
发表于:
2015-02-04
查阅全文...
Creon 25000 CapsulesPancreatin
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:
admin
发表于:
2015-02-04
查阅全文...
Creon 40000 CapsulesPancreatin
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:
admin
发表于:
2015-02-04
查阅全文...
Creon 10000 CapsulesPancreatin
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:
admin
发表于:
2015-02-04
查阅全文...
STELARA 45 mg solution for injection in pre-filled syringe.S
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:
admin
发表于:
2015-02-03
查阅全文...
Invokana 300 mg film-coated tablets
1.Nameofthemedicinalproduct Invokana300mgfilm-coatedtablets 2.Qualitativeandquantitativecomposition Eachtabletcontainscanagliflozinhemihydrate,equivalentto300mgcanagliflozi..
录入者:
admin
发表于:
2015-02-02
查阅全文...
Invokana 100 mg film-coated tablets
1.Nameofthemedicinalproduct Invokana100mgfilm-coatedtablets 2.Qualitativeandquantitativecomposition Eachtabletcontainscanagliflozinhemihydrate,equivalentto100mgcanagliflozi..
录入者:
admin
发表于:
2015-02-02
查阅全文...
Perfalgan 10mg/ml Solution for Infusion
1.Nameofthemedicinalproduct PERFALGAN10mg/ml,solutionforinfusion. 2.Qualitativeandquantitativecomposition Onemlcontains10mgparacetamol One50mlvialcontains500mgparacet..
录入者:
admin
发表于:
2015-02-01
查阅全文...
Vargatef 150 mg soft capsules
1.Nameofthemedicinalproduct Vargatef150mgsoftcapsules 2.Qualitativeandquantitativecomposition Eachcapsulecontains150mgnintedanib(asesilate). Excipientswithknowneffect..
录入者:
admin
发表于:
2015-02-01
查阅全文...
Vargatef 100 mg soft capsules
1.Nameofthemedicinalproduct Vargatef100mgsoftcapsules 2.Qualitativeandquantitativecomposition Eachcapsulecontains100mgnintedanib(asesilate). Excipientswithknowneffect..
录入者:
admin
发表于:
2015-02-01
查阅全文...
Replagal 1 mg/ml concentrate for solution for infusion.Agals
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:
admin
发表于:
2015-02-01
查阅全文...
ZYPREXA* 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, and 20 mg coate
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:
admin
发表于:
2015-01-29
查阅全文...
ZYPREXA* 10 mg Powder for Solution for Injection.Olanzapine
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:
admin
发表于:
2015-01-29
查阅全文...
Benlysta 120 mg and 400 mg powder for concentrate for solution for ..
1.Nameofthemedicinalproduct Benlysta®▼120mgpowderforconcentrateforsolutionforinfusion. Benlysta®▼400mgpowderforconcentrateforsolutionforinfusion. 2.Qualitativeandquantitative..
录入者:
admin
发表于:
2015-01-28
查阅全文...
CONCERTA XL 27 mg prolonged-release tablets.Methylphenidate
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..
录入者:
admin
发表于:
2015-01-28
查阅全文...
CONCERTA XL 18 mg prolonged-release tablets.CONCERTA XL 36 m
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:
admin
发表于:
2015-01-28
查阅全文...
MULTAQ 400 mg film-coated tabletsDronedarone Hydrochloride
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:
admin
发表于:
2015-01-25
查阅全文...
Multaq 400mg tablets
1.Nameofthemedicinalproduct MULTAQ400mgfilm-coatedtablets 2.Qualitativeandquantitativecomposition Eachtabletcontains400mgofdronedarone(ashydrochloride). Excipientwith..
录入者:
admin
发表于:
2015-01-25
查阅全文...
首页
上一页
24
25
26
27
28
29
30
下一页
尾页
27
/66/1301
相关栏目
Greece[希腊药品]
Belgium 比利时药品
Basic Ointments
Norway
holland[荷兰药品]
Turkey
Anti-Inflammatory
Schweiz[瑞士药品]
Homeopathic
Hungary(匈牙利药品)
Finland(芬兰)
Taiwan
Denmark[丹麦药品]
Vitamin
United Kingdom[英国药品]
Sweden[瑞典药品]
Portugal[葡萄牙药品]
Antibacterials
Thailand
China
Russia[俄罗斯药品]
Miscellaneous
Dental and Oral
Herbs and Natural Products
Antiallergic Agents
India
Germany[德国药品]
Japan[日本药品]
Lithuania
British
Italy[意大利药品]
South Korea[韩国药品]
France[法国药品]
Ireland[爱尔兰药品]
Medical Devices
Spain[西班牙药品]
America[美国药品]
South Africa[南非药品]
Slovakia[斯洛伐克药品]
Hong Kong[香港药品]
Norway[挪威药品]
Romania[罗马尼亚药品]
European Community
Australia[澳大利亚药品]
Antipruritics and
Antivirals
Canada[加拿大药品]
热门文章
推荐文章
广告位
Copyright@http://www.120ty.net all rights reserved
Powered by
ftfxkj V7.0Final
Code © 2003-11
ftfxkj